Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;89(11):5772-87.
doi: 10.1128/JVI.03628-14. Epub 2015 Apr 1.

Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy

Affiliations

Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy

G Matusali et al. J Virol. 2015 Jun.

Abstract

A number of men receiving prolonged suppressive highly active antiretroviral therapy (HAART) still shed human immunodeficiency virus (HIV) in semen. To investigate whether this seminal shedding may be due to poor drug penetration and/or viral production by long-lived cells within male genital tissues, we analyzed semen and reproductive tissues from macaques chronically infected with simian immunodeficiency virus mac251 (SIVmac251) who were treated for 4 months with HAART, which was intensified over the last 7 weeks with an integrase inhibitor. We showed that a subset of treated animals continued shedding SIV in semen despite efficient HAART. This shedding was not associated with low antiretroviral drug concentrations in semen or in testis, epididymis, seminal vesicles, and prostate. HAART had no significant impact on SIV RNA in the urethra, whereas it drastically reduced SIV RNA levels in the prostate and vas deferens and to a lesser extent in the epididymis and seminal vesicle. The only detectable SIV RNA-positive cells within the male genital tract after HAART were urethral macrophages. SIV DNA levels in genital tissues were not decreased by HAART, suggesting the presence throughout the male genital tract of nonproductively infected cells. In conclusion, our results demonstrate that 4 months of HAART induced variable and limited control of viral infection in the male reproductive organs, particularly in the urethra, and suggest that infected long-lived cells in the male genital tract may be involved in persistent seminal shedding during HAART. These results pave the way for further investigations of male genital organ infection in long-term-treated infected individuals.

Importance: A substantial subset of men receiving prolonged HAART suppressing viral loads in the blood still harbor HIV in semen, and cases of sexual transmission have been reported. To understand the origin of this persistence, we analyzed the semen and male reproductive tissues from SIV-infected macaques treated with HAART. We demonstrated that persistent seminal shedding was not linked to poor drug penetration in semen or semen-producing prostate, seminal vesicle, epididymis, and testis. We revealed that HAART decreased SIV RNA to various extents in all male genital organs, with the exception of the urethra, in which SIV RNA(+) macrophages were observed despite HAART. Importantly, HAART did not impact SIV DNA levels in the male genital organs. These results suggest that infection of male genital organs, and particularly the urethra, could be involved in the release of virus in semen during HAART.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Impact of treatment on viral load and viral dynamics in the blood. (A) Comparison of blood viral loads in untreated (n = 8) and treated (n = 6) macaques before and at the end of treatment; (B) longitudinal follow-up of blood viral loads in treated animals (n = 6) before and over the course of antiretroviral treatment. Vertical lines indicate the initiation of therapy (HAART) and of intensification (iHAART). Each symbol represents one macaque. Statistical analysis with nonparametric test: Mann-Whitney test (untreated versus treated) and Wilcoxon signed-rank test (treated before HAART versus treated at euthanasia). Dotted lines represent the detection limit of the assay for vRNA (12 copies/ml). The gray areas delineate plasma viral loads of ≤100 copies/ml.
FIG 2
FIG 2
Impact of treatment on viral load and viral dynamics in semen. (A) Comparison of semen viral loads in untreated (n = 6) and treated (n = 6) macaques before and at the end of treatment; (B) longitudinal follow-up of semen viral loads in treated animals (n = 6) before and over the course of antiretroviral treatment. Vertical lines indicate the initiation of therapy (HAART) and of intensification (iHAART). Each symbol represents one macaque. Statistical analysis with nonparametric test: Mann-Whitney test (untreated versus treated) and Wilcoxon signed-rank test (treated before HAART versus treated at euthanasia). Dotted lines represent the detection limit of the assay for vRNA (12 copies/ml).
FIG 3
FIG 3
Impact of treatment on SIV DNA levels in lymphoid and MGT tissues. (A) Axillary lymph node biopsy specimens were collected from treated animals before and after 4 months of HAART for SIV DNA quantification. SIV DNA was measured in the spleen (B) and MGT tissues (C) from treated and untreated animals, using a two-step quantitative PCR. Each symbol in the graph represents the mean from two tissue fragments from one animal. Dotted lines represent the detection limit of the SIV DNA quantitative assay. Statistical analysis with a Mann-Whitney nonparametric test.
FIG 4
FIG 4
Impact of treatment on SIV RNA levels in spleen and MGT tissues. SIV RNA was measured in the spleen (A) and MGT tissues (B) from treated and untreated animals using a two-step quantitative RT-PCR. Each symbol in the graph represents the mean from two tissue fragments from one animal. Dotted lines represent the detection limit of the SIV RNA quantitative assay. Statistical analysis with a Mann-Whitney nonparametric test.
FIG 5
FIG 5
Detection and localization of SIV-infected cells in the MGT tissues by in situ hybridization. (A) Positive control, sections of mesenteric lymph node from an untreated animal hybridized with SIV antisense probe showing infected cells (arrows); (B) negative control, parallel sections of mesenteric lymph node hybridized with SIV sense probe showing no signal; urethra from untreated (C) and treated (D) macaques displaying infected cells (arrows); (E) hybridization of parallel sections of urethra with SIV sense probe showing no signal for SIV RNA (negative control); (F) prostate from untreated macaque displaying infected cells (arrows). Scale bar = 50 μm.
FIG 6
FIG 6
Concentrations of antiretroviral drugs in blood, semen, and MGT tissues. Blood plasma (A) and seminal plasma (B) concentrations of emtricitabine (FTC), tenofovir (TFV), lopinavir (LPV), ritonavir (RTV), and raltegravir (RAL) measured 24 h postadministration (C24h) 120 days post-HAART at the time of euthanasia. (C) MGT tissue concentrations (ng/g) of emtricitabine-triphosphate (FTC-TP), tenofovir-diphosphate (TFV-DP), lopinavir (LPV), ritonavir (RTV), and raltegravir (RAL) in the MGT tissues (T, testis; E, epididymis; P, prostate; SV, seminal vesicles). Each symbol in the graphs represents one macaque.
FIG 7
FIG 7
Quantification of SIV target cells and immune cell foci in the MGT tissues. (A) Quantitative analysis of the number of scattered macrophages (identified using a combination of antibodies against CD68 and CD163) and CD4+ T lymphocytes in the urethra, epididymis, and prostate from untreated (white bars) and treated (red bars) animals (n = 3 in each group). (B) Semiquantitative analysis of the number of HLA-DR+ immune cell foci in epididymis and prostate from untreated (white bars, n = 8) and HAART-treated (red bars, n = 6) macaques. Cell foci were divided into three categories based on the number of cells they encompassed: small foci (between 15 and 49 HLA-DR+ cells), medium foci (between 50 and 200 cells), and large foci (over 200 cells). Numbers of cells in each focus category are indicated on the x axis. Histograms represent the means ± standard errors of the mean (SEM) of the number of cell foci in each category. Statistical analysis with a Mann-Whitney nonparametric test.
FIG 8
FIG 8
Phenotyping of SIV RNA+ cells in the MGT tissues by combined immunofluorescence and in situ hybridization. Quadruple label fluorescence microscopy to identify macrophages (CD68/CD163, red), T lymphocytes (CD3, white), and SIV RNA expression (ISH, green). Cell nuclei are stained by DAPI (blue). (A) Positive control, tissue sections hybridized with antisense probe showing infected T lymphocytes (arrows) in the seminal vesicle from a highly (acutely) infected animal; (B) negative control, parallel tissue sections of seminal vesicle hybridized with SIV sense probe showing no signal for SIV RNA; (C, E, F) urethra from treated macaques displaying SIV RNA+ macrophages (arrowheads); (D) negative control, hybridization of parallel sections of urethra with SIV sense probe showing no specific signal for SIV RNA; (G) prostate from untreated chronic macaque displaying infected T lymphocyte (arrow). Large panels represent merged images combining all channels. Side panels represent individual channels. Scale bar = 20 μm.

Similar articles

Cited by

References

    1. UNAIDS. 2013. Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland.
    1. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, Campbell MS, Mullins JI, Celum C. 2011. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 3:77ra29. doi:10.1126/scitranslmed.3001888. - DOI - PMC - PubMed
    1. European Study Group on Heterosexual Transmission of HIV. 1992. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 304:809–813. doi:10.1136/bmj.304.6830.809. - DOI - PMC - PubMed
    1. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. 1997. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 146:350–357. doi:10.1093/oxfordjournals.aje.a009276. - DOI - PubMed
    1. Baeten JM, Overbaugh J. 2003. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr HIV Res 1:69–86. doi:10.2174/1570162033352110. - DOI - PubMed

MeSH terms

Substances